Evidence map›Paper›PMID 34115771›Full record

ArticlePloS one2021

Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.

Esther N van der Zee, Lianne M Noordhuis, Jelle L Epker, Nikki van Leeuwen, Bas P L Wijnhoven, Dominique D Benoit, Jan Bakker, Erwin J O Kompanje

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Acute neurological dysfunction in critically ill patients with solid tumors: A 14-year retrospective study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Esther N van der ZeeDepartment of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0003-0431-4659
Lianne M NoordhuisDepartment of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands.
Jelle L EpkerDepartment of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands.
Nikki van LeeuwenDepartment of Public Health, Center for Medical Decision Making, Erasmus University Medical Center, Rotterdam, The Netherlands.
Bas P L WijnhovenDepartment of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Dominique D BenoitDepartment of Intensive Care, Ghent University Hospital, Ghent, Belgium.
Jan BakkerDepartment of Pulmonology and Critical Care, New York University NYU Langone Medical Center, New York, NY, United States of America.
Erwin J O KompanjeDepartment of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLGhent University Hospital · BEPontificia Universidad Católica de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGiven clinicians' frequent concerns about unfavourable outcomes, Intensive Care Unit (ICU) triage decisions in acutely ill cancer patients can be difficult, as clinicians may have doubts about the appropriateness of an ICU admission. To aid to this decision making, we studied the survival and performance status of cancer patients 2 years following an unplanned ICU admission. MATERIALS AND

methodsThis was a retrospective cohort study in a large tertiary referral university hospital in the Netherlands. We categorized all adult patients with an unplanned ICU admission in 2017 into two groups: patients with or without an active malignancy. Descriptive statistics, Pearson's Chi-square tests and the Mann-Whitney U tests were used to evaluate the primary objective 2-year mortality and performance status. A good performance status was defined as ECOG performance status 0 (fully active) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out light work). A multivariable binary logistic regression analysis was used to identify factors associated with 2-year mortality within cancer patients.

resultsOf the 1046 unplanned ICU admissions, 125 (12%) patients had cancer. The 2-year mortality in patients with cancer was significantly higher than in patients without cancer (72% and 42.5%, P <0.001). The median performance status at 2 years in cancer patients was 1 (IQR 0-2). Only an ECOG performance status of 2 (OR 8.94; 95% CI 1.21-65.89) was independently associated with 2-year mortality.

conclusionsIn our study, the majority of the survivors have a good performance status 2 years after ICU admission. However, at that point, three-quarter of these cancer patients had died, and mortality in cancer patients was significantly higher than in patients without cancer. ICU admission decisions in acutely ill cancer patients should be based on performance status, severity of illness and long-term prognosis, and this should be communicated in the shared decision making. An ICU admission decision should not solely be based on the presence of a malignancy.

Indexed as

AgedClinical Decision-MakingFemaleHumansIntensive Care UnitsMaleMiddle AgedMortalityNeoplasmsPatient AdmissionSurvival AnalysisTriage

Identifiers

PMID34115771
PMCPMC8195393
OpenAlexW3168422525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.